The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -38.76%.However, over the last six months, we can see a stronger performance of -41.70%. Over the last 30 days, the price of BVS has leaped by -7.22%. And in the last five days, it has fallen by -4.17%.
Bioventus Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $14.38 on 11/04/24 and the lowest value was $5.28 on 06/26/24.
52-week price history of BVS Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Bioventus Inc’s current trading price is -55.29% away from its 52-week high, while its distance from the 52-week low is 21.78%. The stock’s price range during this period has varied between$5.28 and $14.38. The Bioventus Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.28 million for the day, a figure considerably lower than their average daily volume of 0.38 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Bioventus Inc (BVS) has experienced a quarterly decline of -35.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 528.19M and boasts a workforce of 930 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
BVS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BVS stands at 2.40. Similarly, the long-term debt-to-equity ratio is also 2.13.
